Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial [CONgenitale Cmv: Effectiviteit van antivirale therapie in een geRandomiseerde gecontroleerd Trial]
Phase of Trial: Phase III
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections; Sensorineural hearing loss
- Focus Therapeutic Use
- Acronyms CONCERT
- 24 Jun 2015 Last checked against ClinicalTrials.gov record.
- 04 Nov 2013 Planned end date changed from 1 Jun 2015 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 04 Nov 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.